IN2014DN07019A - - Google Patents

Info

Publication number
IN2014DN07019A
IN2014DN07019A IN7019DEN2014A IN2014DN07019A IN 2014DN07019 A IN2014DN07019 A IN 2014DN07019A IN 7019DEN2014 A IN7019DEN2014 A IN 7019DEN2014A IN 2014DN07019 A IN2014DN07019 A IN 2014DN07019A
Authority
IN
India
Prior art keywords
positive
methods
cancer
mammalian subject
diagnosing
Prior art date
Application number
Other languages
English (en)
Inventor
Hans Peter Gerber
Dena Marrinucci
Shepherd Steven Pirie
Eric Tucker
Original Assignee
Pfizer
Epic Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Epic Sciences Inc filed Critical Pfizer
Publication of IN2014DN07019A publication Critical patent/IN2014DN07019A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5759
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • G01N33/575
    • G01N33/5758
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70589CD45

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
IN7019DEN2014 2012-01-24 2013-01-22 IN2014DN07019A (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261590066P 2012-01-24 2012-01-24
US201361753665P 2013-01-17 2013-01-17
PCT/IB2013/050547 WO2013111054A1 (en) 2012-01-24 2013-01-22 Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject

Publications (1)

Publication Number Publication Date
IN2014DN07019A true IN2014DN07019A (enExample) 2015-04-10

Family

ID=47844410

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7019DEN2014 IN2014DN07019A (enExample) 2012-01-24 2013-01-22

Country Status (14)

Country Link
US (1) US10254286B2 (enExample)
EP (1) EP2807485B1 (enExample)
JP (1) JP6254951B2 (enExample)
KR (1) KR101716555B1 (enExample)
CN (1) CN104094116B (enExample)
AU (2) AU2013213301A1 (enExample)
BR (1) BR112014018192A8 (enExample)
CA (1) CA2861437C (enExample)
ES (1) ES2724232T3 (enExample)
IL (1) IL233543B (enExample)
IN (1) IN2014DN07019A (enExample)
MX (1) MX361058B (enExample)
RU (1) RU2646498C2 (enExample)
WO (1) WO2013111054A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2803804B2 (ja) 1992-08-21 1998-09-24 株式会社長澤製作所 ボタン錠
CN102782498A (zh) 2009-10-21 2012-11-14 斯克里普斯研究所 用非稀有细胞检测稀有细胞的方法
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
WO2015172038A1 (en) * 2014-05-09 2015-11-12 The Scripps Research Institute Compositions and methods for fluid biopsy of melanoma
US20150185204A1 (en) * 2013-12-30 2015-07-02 The Scripps Research Institute Circulating tumor cell diagnostics for lung cancer
WO2015112955A1 (en) 2014-01-27 2015-07-30 Epic Sciences, Inc. Circulating tumor cell diagnostics for prostate cancer biomarkers
US10545151B2 (en) * 2014-02-21 2020-01-28 Epic Sciences, Inc. Methods for analyzing rare circulating cells
WO2015155345A1 (en) * 2014-04-11 2015-10-15 Medimmune Limited Antibodies and antibody-drug conjugates
JP6657509B2 (ja) * 2014-08-25 2020-03-04 クリエイティブ マイクロテック インコーポレイテッドCreatv Microtech, Inc. 疾患の検出及び診断のための血液中の循環細胞バイオマーカーの使用並びにそれらを単離する方法
CN113552350B (zh) * 2015-04-21 2024-10-11 基因泰克公司 用于前列腺癌分析的组合物和方法
KR102696044B1 (ko) * 2015-11-06 2024-08-16 벤타나 메디컬 시스템즈, 인코포레이티드 대표 진단법
KR20170099738A (ko) 2016-02-23 2017-09-01 노을 주식회사 접촉식 염색 패치 및 그 제조 방법
KR102478639B1 (ko) 2016-02-23 2022-12-19 노을 주식회사 표지 물질을 저장하는 패치, 이를 이용하는 조직 진단 방법 및 장치
KR102406596B1 (ko) * 2016-02-23 2022-06-10 노을 주식회사 패치를 이용하는 ctc 진단 방법 및 장치
KR102045069B1 (ko) * 2016-02-23 2019-11-15 노을 주식회사 패치를 이용하는 ctc 진단 방법 및 장치
US10371610B2 (en) 2016-02-23 2019-08-06 Noul Co., Ltd. Contact-type patch, staining method using the same, and manufacturing method thereof
RU2019134462A (ru) 2017-04-03 2021-05-05 Ф. Хоффманн-Ля Рош Аг Антитела, связывающиеся с steap-1
CN111033238A (zh) * 2017-06-27 2020-04-17 定量癌症诊断有限责任公司 定量的液体活检诊断系统与方法
CN107918013A (zh) * 2017-09-25 2018-04-17 浙江天科高新技术发展有限公司 化学发光酶免测定循环肿瘤细胞中K‑Ras蛋白的方法及试剂盒
JP7678424B2 (ja) 2018-05-10 2025-05-16 学校法人順天堂 画像解析方法、装置、コンピュータプログラム、及び深層学習アルゴリズムの生成方法
WO2020086882A1 (en) * 2018-10-24 2020-04-30 Northwestern University Tumor cell aggregation inhibitors' for treating cancer
JP7381003B2 (ja) * 2019-04-26 2023-11-15 学校法人順天堂 疾患解析を支援する方法、装置、及びコンピュータプログラム、並びにコンピュータアルゴリズムを訓練する方法、装置、及びプログラム
US20230175073A1 (en) 2021-12-07 2023-06-08 Epic Sciences, Inc. Enhanced characterization of breast cancer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391904A (en) 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
US5869053A (en) 1988-03-04 1999-02-09 Cancer Research Campaign Technology, Ltd. 5T4 antigen from human trophoblasts
EP0336562B1 (en) 1988-03-04 1995-06-14 Cancer Research Campaign Technology Ltd. Improvements relating to antigens
JP2002507117A (ja) 1997-06-04 2002-03-05 オックスフォード・バイオメディカ・(ユーケイ)・リミテッド ベクター
JP2003515323A (ja) 1999-11-18 2003-05-07 オックスフォード バイオメディカ(ユーケイ)リミテッド 抗 体
GB0126378D0 (en) 2001-11-02 2002-01-02 Oxford Biomedica Ltd Antigen
US7305112B2 (en) 2002-10-15 2007-12-04 The Scripps Research Institute Method of converting rare cell scanner image coordinates to microscope coordinates using reticle marks on a sample media
KR20070050956A (ko) * 2004-09-10 2007-05-16 와이어쓰 사람화 항-5t4 항체 및 항-5t4 항체/칼리케아미신 접합체
JP2009525468A (ja) * 2006-01-30 2009-07-09 ザ・スクリプス・リサーチ・インステイチユート 循環腫瘍細胞の検出方法および哺乳類対象における癌の診断方法
JP5523824B2 (ja) 2006-03-10 2014-06-18 ワイス・エルエルシー 抗−5t4抗体およびその使用
US20100233693A1 (en) 2007-04-16 2010-09-16 On-O-ity, Inc Methods for diagnosing, prognosing, or theranosing a condition using rare cells
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method
CN102414562B (zh) 2009-03-24 2019-05-07 生物概念股份有限公司 细胞捕获和分析的装置和方法
CA2754610C (en) 2009-03-27 2015-05-05 Marc Isaac Damelin Tumor-initiating cells and methods for using same
US20120178094A1 (en) 2009-09-03 2012-07-12 Peter Kuhn Method for Categorizing Circulating Tumor Cells
CN102782498A (zh) 2009-10-21 2012-11-14 斯克里普斯研究所 用非稀有细胞检测稀有细胞的方法
CA2795776A1 (en) * 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers for disease
EP2591363B1 (en) 2010-07-07 2017-09-20 The Regents Of The University Of Michigan Diagnosis and treatment of breast cancer
AU2012235817B2 (en) 2011-04-01 2016-03-10 Wyeth Llc Antibody-drug conjugates

Also Published As

Publication number Publication date
JP6254951B2 (ja) 2017-12-27
CA2861437A1 (en) 2013-08-01
KR101716555B1 (ko) 2017-03-14
CN104094116B (zh) 2017-05-31
RU2014127474A (ru) 2016-03-20
CN104094116A (zh) 2014-10-08
AU2013213301A1 (en) 2014-07-17
US20150017661A1 (en) 2015-01-15
CA2861437C (en) 2018-08-21
WO2013111054A1 (en) 2013-08-01
MX2014008928A (es) 2014-10-24
BR112014018192A8 (pt) 2021-03-02
IL233543A0 (en) 2014-08-31
EP2807485B1 (en) 2019-03-13
RU2646498C2 (ru) 2018-03-05
IL233543B (en) 2018-02-28
HK1202923A1 (en) 2015-10-09
ES2724232T3 (es) 2019-09-09
KR20140100580A (ko) 2014-08-14
MX361058B (es) 2018-11-23
EP2807485A1 (en) 2014-12-03
AU2018220154A1 (en) 2018-09-13
US10254286B2 (en) 2019-04-09
JP2015507190A (ja) 2015-03-05

Similar Documents

Publication Publication Date Title
IN2014DN07019A (enExample)
IL225646A0 (en) Methods and kits for detecting cancer cells in the circulation of pancreatic patients using polyspecific capture and cocktail detection reagents
MX2013000917A (es) Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
MY188938A (en) Therapeutic, diagnostic and prognostic methods for cancer of the bladder
EP2524059A4 (en) DETECTION OF GASTROINTESTINAL DISEASES
GB2519906A (en) Methods and systems for detecting biological components
WO2007089911A3 (en) Methods for detection of circulating tumor cells and methods of diagnosis of cancer in a mammalian subject
HK1255533A1 (zh) 用於检测大肠癌及进阶性腺瘤的蛋白质生物标志物面板
MY197809A (en) Biomarkers and methods of treating pd-1 and pd-l1 related conditions
MY170983A (en) Biomarker assays for detecting or measuring inhibition of tor kinase activity
EP4497824A3 (en) Methods and materials for assessing loss of heterozygosity
WO2013138522A3 (en) Methods for assessing effectiveness and monitoring oncolytic virus treatment
EP4219765A3 (en) Prostate cancer prognosis using biomarkers
WO2012135844A3 (en) Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers
EP2576837A4 (en) CIRCULATING NUCLEIC ACID BIOMARKERS ASSOCIATED WITH PROSTATE CANCER
WO2013036543A3 (en) Molecular imaging of cancer cells in vivo
EP2833149A4 (en) METHOD FOR DETECTING THE MALIGNANCE DEGREE OF A CIRCULATING TUMOR CELL UNIT AND KIT THEREFOR
NZ629555A (en) Monocyte biomarkers for cancer detection
WO2014078468A3 (en) Biomarkers for predicting clinical response of cancer patients to treatment with immunotherapeutic agent
EP3100046A4 (en) Detection of prostate specific membrane antigen (psma) expression on circulating tumor cells (ctc)
WO2012012694A3 (en) Methods of detecting autoimmune or immune-related diseases or conditions
GB2535914B (en) Biomarkers useful for detection of types, grades and stages of human breast cancer
EP3385717A3 (en) Methods of detecting prostate cancer
WO2013081645A3 (en) Erbb3 mutations in cancer
EP2855705A4 (en) CANCER DIAGNOSIS METHOD WITH DETECTION OF THE METHYLATION SIGNATURE IN THE HTERT PROMOTER